10.350
+0,00%
2026-10-19
Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +17.6% | +103.9% | 3 / 3 | +124.6% | -4.97 pp | -1.97 pp | +10.3% | 0.27 | 8.48 | 297 | +124,6% | 18,4 | +70,4% | 8.48 | 17.49 | −51,5% |
| Pts | 0 | 12 | 12 | 12 | 0 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 10.350 (close price on 2026-10-19)EPS (TTM): 1.221
Financial charts
1.Revenue & growth
VND bn297Q2/26
1.Revenue & growth
VND bn297Q2/26
2.Profit & growth
VND bn18,5Q2/26
3.Profit mix (Penman)
VND bn84,9Q2/26
4.Margins & cost structure
%10.9%Q2/26
5.Returns & cash cycle
% · days10.1%Q2/26
6.Earnings quality & cash
VND bn-211Q2/26
7.Asset structure
VND bn1.388Q2/26
8.Funding & debt health
VND bn · times1.388Q2/26
9.Revenue backlog
VND bn98,7Q2/26
10.Valuation
times · %11,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %264Q2/26
Adjusted EPS growth, latest quarter
18.0%
Average adjusted EPS growth, 3 quarters
104%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
46.0%
Source: vnstockData through Q2/26